HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plaintiff Digs Deep In Almay Archives For ‘Hypoallergic’ Fraud Evidence

This article was originally published in The Rose Sheet

Executive Summary

In the absence of FDA regulations, federal courts generally are weighing hypoallergenic false-advertising arguments against the “reasonable consumer” standard, with varying results. However, Almay may have provided a more substantive basis for assessing the truthfulness of its hypoallergenic claims via a letter to FDA on the subject – albeit one from 1973.

Advertisement

Related Content

Target Cruises Past Hypoallergenic Cosmetic Suit, But Other Defendants On Rockier Road
Revlon Highlights Flesh Beauty Launch, China Momentum In Q2 Report
J&J Scores Early In ‘Hypoallergenic’ Case; Plaintiff’s Definition ‘Implausible,’ Court Says
Whole Foods ‘Hypoallergenic’ Litigation To Test ‘Sensitizer’ Definition, Consumer Perceptions
Target, Whole Foods Have Irritated Reactions To ‘Hypoallergenic’ Product Suits

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS121777

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel